Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP650921.RAAp_FQKJ5M6GmPlck-rz9fv44FVAXaNOIe6UbZW-wjHg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP650921.RAAp_FQKJ5M6GmPlck-rz9fv44FVAXaNOIe6UbZW-wjHg130_assertion type Assertion NP650921.RAAp_FQKJ5M6GmPlck-rz9fv44FVAXaNOIe6UbZW-wjHg130_head.
- NP650921.RAAp_FQKJ5M6GmPlck-rz9fv44FVAXaNOIe6UbZW-wjHg130_assertion description "[Based on our encouraging results of G-CSF-primed HLA-matched related marrow transplants for high-risk leukemia, we extended the study from matched related to haploidentical transplants using G-CSF primed marrow and sequential immunosuppressants to prevent both graft-versus-host disease (GVHD) and host-versus-graft rejection (HVGR).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP650921.RAAp_FQKJ5M6GmPlck-rz9fv44FVAXaNOIe6UbZW-wjHg130_provenance.
- NP650921.RAAp_FQKJ5M6GmPlck-rz9fv44FVAXaNOIe6UbZW-wjHg130_assertion evidence source_evidence_literature NP650921.RAAp_FQKJ5M6GmPlck-rz9fv44FVAXaNOIe6UbZW-wjHg130_provenance.
- NP650921.RAAp_FQKJ5M6GmPlck-rz9fv44FVAXaNOIe6UbZW-wjHg130_assertion SIO_000772 12476277 NP650921.RAAp_FQKJ5M6GmPlck-rz9fv44FVAXaNOIe6UbZW-wjHg130_provenance.
- NP650921.RAAp_FQKJ5M6GmPlck-rz9fv44FVAXaNOIe6UbZW-wjHg130_assertion wasDerivedFrom befree-20140225 NP650921.RAAp_FQKJ5M6GmPlck-rz9fv44FVAXaNOIe6UbZW-wjHg130_provenance.
- NP650921.RAAp_FQKJ5M6GmPlck-rz9fv44FVAXaNOIe6UbZW-wjHg130_assertion wasGeneratedBy ECO_0000203 NP650921.RAAp_FQKJ5M6GmPlck-rz9fv44FVAXaNOIe6UbZW-wjHg130_provenance.